Yang, Yun
Wei, Yinhao
Sun, Yiying
Zhou, Yong
Yang, Hanshuo
Funding for this research was provided by:
National Natural Science Foundation of China (81572402)
Article History
Received: 12 May 2024
Revised: 16 June 2024
Accepted: 26 June 2024
First Online: 29 July 2024
Competing interests
: The authors declare no competing interests.
: This study was conducted in strict adherence to ethical standards and guidelines. All animal experiments were conducted in the State Key Laboratory of Biotherapy of Sichuan University, following the approval and oversight of the Animal Ethics Committee of Sichuan University (20210409043). The welfare of the animals was diligently maintained throughout the entire study. Human liver cancer tissue microarrays were sourced from OUTDO BIOTECH CO., LTD (Shanghai, China) through commercial channels. The acquisition and use of these human tissue samples strictly adhered to all applicable laws, regulations, and ethical standards. Confidentiality of patient information was upheld at all times. The authors affirm that the research was conducted with integrity and in full compliance with all relevant ethical principles.